Evaluation of xanthan and highly substituted galactomannan from M. scabrella as a sustained release matrix

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 197-205

  Ughini, F ^a   Andreazza, I F ^a   Ganter, J L M S ^b   Bresolin, T M B ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Diclofenac sodium; Drug release; Galactomannan; Xanthan

Indexed keywords

DICLOFENAC; GALACTOMANNAN; HYDROXYPROPYLMETHYLCELLULOSE; XANTHAN;

ARTICLE; CONTROLLED DRUG RELEASE; DISSOLUTION; DOSE RESPONSE; DRUG CAPSULE; DRUG ISOLATION; DRUG SCREENING; HYDROPHILICITY; MEDICINAL PLANT; MIMOSA SCABRELLA; PH MEASUREMENT; PRIORITY JOURNAL; SUBSTITUTION REACTION; SUSTAINED DRUG RELEASE; TABLET FORMULATION; XANTHOMONAS CAMPESTRIS;

EID: 1142285515     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.11.011     Document Type: Article

References (45)

1. Baichwall A., Neville D.A. Culturing innovation and enhancing medications using oral drug delivery. Drug Deliv. Technol. 2:2002;65-68.
2. Baird J.K., Sandford P.A., Cottrell I.W. Industrial applications of some new microbial polysaccharides. Bio. Technol. 1:1983;778.
3. Bamba M., Puisieux F., Marty J.P., Carstensen J.T. Release mechanisms in gel forming sustained release preparations. Int. J. Pharm. 2:1979;307-315.
4. Baveja S.K., Rao R.K.V., Arora J., Mathur N.K., Vinayak V.K. Chemical investigations of some galactomannan gums as matrix tablets for sustained drug delivery. Indian J. Chem. 3:1991;133-137.
5. Bayertein, F., 1993. In: Meuser, F., Manners, D.J., Seibel, W. (Eds.), Plant Polymeric Carbohydrates. Royal Society of Chemistry, Cambridge, pp. 191-202.
6. Bergmeier, J.I.U., 1983. Method of Enzymatic Analysis, 3rd ed. Verlag Chemie, Heidelberg.
7. Billa N., Yuen K.H. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharma Sci. Tech. 1:2000;1-8.
8. Bresolin T.M.B., Sander P.C., Reicher F., Sierakowski M.R., Rinaudo M., Ganter J.L.M.S. Viscometric studies on xanthan and galactomannan systems. Carbohydr. Polym. 33:1997;131-138.
9. Bresolin T.M.B., Milas M., Rinaudo M., Reicher F., Ganter J.L.M.S. Role of galactomannan composition on the binary gel formation with xanthan. Int. J. Biol. Macromol. 26:1999;225-231.
10. British Pharmacopeia, 2000. The Stationery Office, London.
11. Colombo P., Conte U., Caram'ella C., Gazzaniga A., La Manna A. Compressed polymeric mini-matrices for drug release control. J. Control. Rel. 1:1985;283-289.
12. Colombo P., Bettini R., Massimo G., Cattelani P.L., Santi P., Peppas N.A. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pharm. Sci. 84:1995;991-997.
13. Cox P.J., Khan K.A., Munday D.L., Sujja-areevath J. Development and evaluation of a multiple-unit release dosage form for S(+)-ibuprofen: preparation and release kinetics. Int. J. Pharm. 193:1999;73-84.
14. Dea I.C.M., Morrison A. Chemistry and interactions of seed galactomannan. Adv. Carbohydr. Chem. Biochem. 31:1975;241-252.
15. Dubois M., Gilles K.A., Hamilton J.K., Rebers P.A., Smith F. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28:1956;350.
16. Ford J.L., Rubistein M.H., McCaul F., Hogan J.E., Edgar P.E. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Int. J. Pharm. 40:1987;223-234.
17. Ford J.L., Mitchell K., Rowe P., Armstrong D.J., Elliot P.N.C., Rostron C., Hogan J.E. Mathematical modelling of drug release from hydroxypropylmethylcellulose matrices: effect of temperature. Int. J. Pharm. 71:1991;95-104.
18. Ganter J.L.M.S., Milas M., Corrêa J.B.C., Reicher F., Rinaudo M. Study of solutions properties of galactomannan from the seeds of Mimosa scabrella. Carbohydr. Pol. 17:1992;171-175.
19. Ganter J.L.M.S., Reicher F. Water-soluble galactomannans from seeds of Mimosaceae spp. Bioresource Technol. 68:1999;55-62.
20. Higuchi T. Mechanism of sustained-release medication - theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52:1963;1145-1149.
21. Khullar P., Khar R., Agarwal S.P. Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev. Ind. Pharm. 24:1998;1095-1099.
22. Kibbe, A.H., 2000. Handbook of Pharmaceutical Excipients, 3rd ed. APA, Washington.
23. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15:1983;25-35.
24. Kudela, V., 1987. Hydrogels. In: Encyclopedia of Polymer Science and Engineering, 7 ed. Wiley, New York, pp. 783-807.
25. Lapidus H., Lordi G.N. Drug release from compressed hydrophyllic matrices. J. Pharm. Sci. 57:1968;1292-1301.
26. Leuenberger H., Bonny J.D., Lerk c.f., Vromans H. Relationship between crushing strength and internal specific surface area of lactose compacts. Int. J. Pharm. 52:1989;91-100.
27. Lu M.F., Woodward L., Borodkin S. Xanthan gum and alginate based controlled release theophylline formulations. Drug Dev. Ind. Pharm. 17:1991;1987-2004.
28. McCall T.W., Baichwall A.R. In vitro-in vivo correlation of TIMERx-metoprolol products. Proc. Int. Symp. Control. Rel. Bioact. Mater. 21:1994;812-813.
29. Millane R.P., Wang B. A cellulose-like conformation accessible to the xanthan backbone and implications for xanthan synergism. Carbohydr. Pol. 13:1990;57.
30. Möckel J.E., Lippold B.C. Zero-order release from hydrocolloid matrices. Pharm. Res. 10:1993;1066-1070.
31. Munday D.L., Cox P.J. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int. J. Pharm. 203:2000;179-192.
32. ® retard" tablets. Drugs Made Germ. 17:1974;26.
33. Peppas N.A., Sahlin J.J. A simple equation for the description of solute release. III Coupling of diffusion and relaxation. Int. J. Pharm. 57:1989;169-172.
34. Prasad Y.V.R., Krishnaiah Y.S.R., Satyanarayana S. In vitro evaluation of guar gum as a carrier for colon-specific drug delivery. J. Control Rel. 51:1998;281.
35. Racz, I., 1989. Drug Form. Wiley, Budapest, p. 165.
36. Reynolds, J.F.R., 1989. Martindale: The Extra Pharmacopeia, 29th ed. The Pharmaceutical Press, London.
37. Reynolds T.D., Gehrke S.H., Hussain A.S., Shenouda L.S. Polymer erosion and drug release characterisation of hydroxypropylmethylcellulose matrices. J. Pharm. Sci. 87:1998;1115-1123.
38. Ritger P.L., Peppas N.A. A simple equation for the description of solute release. II Fickian and anamolous from swellable devices. J. Control. Rel. 5:1987;37-42.
39. Rocks J.K. Xanthan gum. Food Technol. 25:1971;22.
40. Staniforth, J.N., Baichwall, A.R., 1993. Synergistically interacting heterodisperse polysaccharides: function in achieving controlled drug delivery. ACS Symp. Ser. No. 520, Chapter 24, pp. 327-350.
41. Sujja-areevath J., Munday D.L., Cox P.J., Khan K.A. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. Eur. J. Pharm. Sci. 6:1998;207-217.
42. Talukdar M.M., Plaizier-Vercammen J. Evaluation of xanthan gum as a hydrophillic matrix for controlled-release dosage forms. Drug Dev. Ind. Pharm. 19:1993;1037-1046.
43. Talukdar M.M., Van den Mooter G., Augustijns P., Tjandra-Maga T., Verbeke N., Kinget R. In vitro evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation. Int. J. Pharm. 169:1998;105-113.
44. Tobyn M.J., Maher J., Challinor C.L., Staniforth J.N. Investigations of the interaction between a novel polysaccharide controlled release matrix and model compounds using ESR. J. Control Rel. 40:1996;147-155.
45. United States Pharmacopeia, 2000. The Pharmacopeial Convention, New York.